Nelson Iván Agudelo Higuita

ORCID: 0000-0002-9363-6280
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Trypanosoma species research and implications
  • Research on Leishmaniasis Studies
  • Parasites and Host Interactions
  • Fungal Infections and Studies
  • Travel-related health issues
  • Mosquito-borne diseases and control
  • Herpesvirus Infections and Treatments
  • Cytomegalovirus and herpesvirus research
  • HIV/AIDS Research and Interventions
  • Malaria Research and Control
  • Parasitic infections in humans and animals
  • Antifungal resistance and susceptibility
  • Congenital Anomalies and Fetal Surgery
  • Insect symbiosis and bacterial influences
  • Antibiotics Pharmacokinetics and Efficacy
  • Viral Infections and Vectors
  • Actinomycetales infections and treatment
  • Chronic Lymphocytic Leukemia Research
  • Antimicrobial Resistance in Staphylococcus
  • Global Maternal and Child Health
  • Parasitic Infections and Diagnostics
  • Bacterial Identification and Susceptibility Testing

University of Oklahoma Health Sciences Center
2007-2025

OU Health
2015-2025

Honduras Foundation for Agricultural Research
2023-2024

University of Oklahoma
2023

The Ohio State University
2020

University of Oklahoma Medical Center
2013

Al Ozonoff Naresh Doni Jayavelu Shanshan Liu Esther Melamed Carly E. Milliren and 95 more Jingjing Qi Linda N. Geng Grace A. McComsey Charles B. Cairns Lindsey R. Baden Joanna Schaenman Albert C. Shaw Hady Samaha Vicki Seyfert‐Margolis Florian Krammer Lindsey B. Rosen Hanno Steen Caitlin Syphurs Ravi Dandekar Casey P. Shannon Rafick‐Pierre Sékaly Lauren I. R. Ehrlich David B. Corry Farrah Kheradmand Mark A. Atkinson Scott C. Brakenridge Nelson Iván Agudelo Higuita Jordan P. Metcalf Catherine L. Hough William B. Messer Bali Pulendran Kari C. Nadeau Mark M. Davis Ana Fernández-Sesma Viviana Simon Harm van Bakel Seunghee Kim‐Schulze David A. Hafler Ofer Levy Monica Kraft Chris Bime Elias K. Haddad Carolyn S. Calfee David J. Erle Charles Langelier Walter L. Eckalbar Steven E. Bosinger Kerry McEnaney Brenda Barton Claudia Lentucci Mehmet Saluvan Ana C. Chang Annmarie Hoch Albert Marisa Tanzia Shaheen Alvin T. Kho Sanya Thomas Jing Chen Maimouna D. Murphy Mitchell Cooney Arash Nemati Hayati Robert W. Bryant James Abraham Scott Presnell Tomasz Jancsyk Cole Maguire Brian Lee Slim Fourati Denise Esserman Leying Guan Jeremy P. Gygi Shrikant Pawar Anderson F. Brito Gabriela K. Fragiadakis Ravi K. Patel Scott J. Tebbutt James A. Overton Randi Vita Kerstin Westendorf Rama Thyagarajan Justin F. Rousseau Dennis Wylie Todd Triplett Erna Milunka Kojic R. Sharon Chinthrajah Neera Ahuja Angela J. Rogers Maja Artandi George A. Yendewa Debra Powell James N. Kim Brent Simmons I. Michael Goonewardene Cecilia M. Smith Mark G. Martens Amy C Sherman Stephen R. Walsh Nicolas C. Issa Ramin Salehi‐Rad Charles S. Dela Cruz

Abstract Post-acute sequelae of SARS-CoV-2 (PASC) is a significant public health concern. We describe Patient Reported Outcomes (PROs) on 590 participants prospectively assessed from hospital admission for COVID-19 through one year after discharge. Modeling identified 4 PRO clusters based reported deficits (minimal, physical, mental/cognitive, and multidomain), supporting heterogenous clinical presentations in PASC, with sub-phenotypes associated female sex distinctive comorbidities. During...

10.1038/s41467-023-44090-5 article EN cc-by Nature Communications 2024-01-03

A patient with well-controlled type 2 diabetes mellitus developed a severe pulmonary infection secondary to Rhizopus spp. after receiving short courses of corticosteroids for respiratory tract infection. He recovered an aggressive surgical intervention and treatment isavuconazole. Patients on chronic corticosteroid therapy have higher risk mucormycosis, but there are much fewer reports mucormycosis occurring in patients only steroid therapy.

10.1016/j.mmcr.2020.05.008 article EN cc-by-nc-nd Medical Mycology Case Reports 2020-05-30
Al Ozonoff Joanna Schaenman Naresh Doni Jayavelu Carly E. Milliren Carolyn S. Calfee and 95 more Charles B. Cairns Monica Kraft Lindsey R. Baden Albert C. Shaw Florian Krammer Harm van Bakel Denise Esserman Shanshan Liu Ana Fernandez Sesma Viviana Simon David A. Hafler Ruth R. Montgomery Steven H. Kleinstein Ofer Levy Christian Bime Elias K. Haddad David J. Erle Bali Pulendran Kari C. Nadeau Mark M. Davis Catherine L. Hough William B. Messer Nelson Iván Agudelo Higuita Jordan P. Metcalf Mark A. Atkinson Scott C. Brakenridge David B. Corry Farrah Kheradmand Lauren I. R. Ehrlich Esther Melamed Grace A. McComsey Rafick‐Pierre Sékaly Joann Diray‐Arce Bjoern Peters Alison D. Augustine Elaine F. Reed Matthew C. Altman Patrice M. Becker Nadine Rouphael Al Ozonoff Joanna Schaenman Naresh Doni Jayavelu Carly E. Milliren Carolyn S. Calfee Charles B. Cairns Monica Kraft Lindsey R. Baden Albert C. Shaw Florian Krammer Harm van Bakel Denise Esserman Shanshan Liu Ana Fernandez Sesma Viviana Simon David A. Hafler Ruth R. Montgomery Steven H. Kleinstein Ofer Levy Chris Bime Elias K. Haddad David J. Erle Bali Pulendran Kari C. Nadeau Mark M. Davis Catherine L. Hough William B. Messer Nelson Iván Agudelo Higuita Jordan P. Metcalf Mark A. Atkinson Scott C. Brakenridge David B. Corry Farrah Kheradmand Lauren I. R. Ehrlich Esther Melamed Grace A. McComsey Rafick‐Pierre Sékaly Joann Diray‐Arce Bjoern Peters Alison D. Augustine Elaine F. Reed Kerry McEnaney Brenda Barton Claudia Lentucci Mehmet Saluvan Ana C. Chang Annmarie Hoch Albert Marisa Tanzia Shaheen Alvin T. Kho Sanya Thomas Jing Chen Maimouna D. Murphy Mitchell Cooney Scott Presnell Gabriela K. Fragiadakis

Better understanding of the association between characteristics patients hospitalized with coronavirus disease 2019 (COVID-19) and outcome is needed to further improve upon patient management.

10.1016/j.ebiom.2022.104208 article EN cc-by-nc-nd EBioMedicine 2022-08-09
Harry Pickering Joanna Schaenman Hoang Van Phan Cole Maguire Alexandra Tsitsiklis and 95 more Nadine Rouphael Nelson Iván Agudelo Higuita Mark A. Atkinson Scott C. Brakenridge Monica Fung William B. Messer Elaine F. Reed Adreanne M. Rivera Harry Pickering Subha Sen David Elashoff Dawn C. Ward Jenny Brook Estefania Ramires-Sanchez Megan Llamas Claudia Perdomo Clara E. Magyar Jennifer A. Fulcher David J. Erle Carolyn S. Calfee Carolyn M. Hendrickson Kirsten N. Kangelaris Nguyễn Hoàng Việt Deanna Lee Suzanna Chak Rajani Ghale Ana Gonzalez Alejandra Jáuregui Carolyn Leroux Luz Torres Altamirano Ahmad Sadeed Rashid Andrew Willmore Prescott G. Woodruff Matthew F. Krummel Sidney Carrillo Alyssa Ward Ravi K. Patel Michael R. Wilson Ravi Dandekar Bonny D. Alvarenga Jayant V. Rajan Andrew Schroeder Gabriela K. Fragiadakis Eran Mick Yanedth Sanchez Guerrero Christina Love Lenka Maliskova Michael Adkisson Aleksandra Leligdowicz Alexander J. Beagle Arjun A. Rao Austin Sigman Bushra Samad Cindy Curiel Cole Shaw Gayelan Tietje-Ulrich Jeff Milush Jonathan P. Singer Joshua Vasquez Kevin Tang Legna Betancourt Lekshmi Santhosh Logan Pierce Maria Paz Michael M. Matthay Neeta Thakur Nicklaus Rodriguez Nicole Sutter Norman L. Jones Pratik Sinha Priya Prasad Raphael Lota Sadeed Rashid Saurabh Asthana Sharvari Bhide Tasha Lea Yumiko Abe‐Jones Lauren I. R. Ehrlich Esther Melamed Cole Maguire Dennis Wylie Justin F. Rousseau Kerin Hurley Janelle Geltman Nadia Siles Jacob E. Rogers Pablo Guaman Tipan Arun K. Boddapati Greg K. Tharp Kathryn L. Pellegrini Brandi Johnson Bernadine Panganiban Christopher Huerta Evan J. Anderson Hady Samaha

Abstract Coronavirus disease 2019 (COVID-19) poses significant risks for solid organ transplant recipients, who have atypical but poorly characterized immune responses to infection. We aim understand the host immunologic and microbial features of COVID-19 in recipients by leveraging a prospective multicenter cohort 86 age- sex-matched with 172 non-transplant controls. find that higher nasal SARS-CoV-2 viral abundance impaired clearance, lower anti-spike IgG levels. In addition, exhibit...

10.1038/s41467-025-55823-z article EN cc-by Nature Communications 2025-01-10
Benjamin Haslund-Gourley Kyra Woloszczuk Jintong Hou Jennifer Connors Gina Cusimano and 95 more Matthew R. Bell Bhavani Taramangalam Slim Fourati Nathan Mege Mariana Bernui Matthew C. Altman Florian Krammer Harm van Bakel Al Ozonoff Lauren I. R. Ehrlich Esther Melamed Ana Fernández-Sesma Viviana Simon Bali Pulendran Kari C. Nadeau Mark M. Davis Grace A. McCoey Rafick‐Pierre Sékaly Lindsey R. Baden Ofer Levy Joanna Schaenman Elaine F. Reed Albert C. Shaw David A. Hafler Ruth R. Montgomery Steven H. Kleinstein Patrice M. Becker Alison D. Augustine Carolyn S. Calfee David J. Erle Michael E. DeBakey David B. Corry Farrah Kheradmand Mark A. Atkinson Scott C. Brakenridge Nelson Iván Agudelo Higuita Jordan P. Metcalf Catherine L. Hough William B. Messer Monica Kraft Chris Bime Bjoern Peters Carly E. Milliren Caitlin Syphurs Kerry McEnaney Brenda Barton Claudia Lentucci Mehmet Saluvan Ana C. Chang Annmarie Hoch Albert Marisa Tanzia Shaheen Alvin T. Kho Shanshan Liu Sanya Thomas Jing Chen Maimouna D. Murphy Mitchell Cooney Arash Nemati Hayati Robert W. Bryant James Abraham Naresh Doni Jayavelu Scott Presnell Tomasz Jancsyk Cole Maguire Jingjing Qi Brian Lee Slim Fourati Denise Esserman Leying Guan Jeremy P. Gygi Shrikant Pawar Anderson F. Brito Gabriela K. Fragiadakis Ravi K. Patel James A. Overton Randi Vita Kerstin Westendorf Casey P. Shannon Scott J. Tebbutt Rama Thyagarajan Justin F. Rousseau Dennis Wylie Todd Triplett Erna Milunka Kojic R. Sharon Chinthrajah Neera Ahuja Angela J. Rogers Maja Artandi Linda N. Geng George A. Yendewa Debra Powell James N. Kim Brent Simmons I. Michael Goonewardene

Abstract The glycosylation of IgG plays a critical role during human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activating immune cells and inducing cytokine production. However, the IgM N-glycosylation has not been studied viral infection. analysis from healthy controls hospitalized disease 2019 (COVID-19) patients reveals increased high-mannose sialylation that correlates with COVID-19 severity. These trends are confirmed within SARS-CoV-2-specific...

10.1038/s41467-023-44211-0 article EN cc-by Nature Communications 2024-01-09

Chronic viral infections are ubiquitous in humans, with individuals harboring multiple latent viruses that can reactivate during acute illnesses. Recent studies have suggested SARS-CoV-2 infection lead to reactivation of such as Epstein-Barr Virus (EBV) and cytomegalovirus (CMV), yet, the extent impact COVID-19 its effect on host immune system remain incompletely understood. Here we present a comprehensive multi-omic analysis all known chronically infecting 1,154 hospitalized patients, from...

10.1101/2024.11.14.622799 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-11-16

Skin and soft tissue infections result from microbial invasion of the skin its supporting structures. Management is determined by severity location infection patient comorbidities. Infections can be classified as simple (uncomplicated) or complicated (necrotizing nonnecrotizing), suppurative nonsuppurative. Most community-acquired are caused methicillin-resistant Staphylococcus aureus beta-hemolytic streptococcus. Simple usually monomicrobial present with localized clinical findings. In...

10.3109/9781420051513-15 article EN CRC Press eBooks 2007-08-22

Human population growth and development coupled with centuries of atmospheric colonization by the world's richest regions have now made evident a potentially irreversible disruption in restoration capacity planet's ecosystems. The production, utilization, consumption animal products has been closely intertwined to human biologic social evolution. This relationship is threatening health equilibrium ecosystem. Global food production responsible for 35% all greenhouse gas emissions (GHGE) use...

10.1016/j.joclim.2023.100260 article EN cc-by The Journal of Climate Change and Health 2023-07-20

The post-acute sequelae of SARS-CoV-2 (PASC), also known as long COVID, remain a significant health issue that is incompletely understood. Predicting which acutely infected individuals will go on to develop COVID challenging due the lack established biomarkers, clear disease mechanisms, or well-defined sub-phenotypes. Machine learning (ML) models offer potential address this by leveraging clinical data enhance diagnostic precision. We utilized data, including antibody titers and viral load...

10.1101/2025.02.12.25322164 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2025-02-13

Following SARS-CoV-2 infection, ∼10-35% of COVID-19 patients experience long COVID (LC), in which often debilitating symptoms persist for at least three months. Elucidating the biologic underpinnings LC could identify therapeutic opportunities. We utilized machine learning methods on analytes and patient reported outcome surveys provided over 12 months after hospital discharge from >500 hospitalized IMPACC cohort to a multi-omics "recovery factor". participants who experienced had lower...

10.1101/2025.02.12.637926 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2025-02-14

Human hookworm infection is caused by the nematodes Necator americanus , Ancylostoma duodenale and ceylanicum . Iron deficiency anemia hallmark of chronic, moderate-to-heavy-intensity infections, promoting a vicious poverty cycle. Overt severe acute life-threatening lower gastrointestinal hemorrhage an extremely rare manifestation infection, as well finding multiple attached to colonic mucosae. This presentation with hematochezia from colon in patient living human immunodeficiency virus...

10.1177/20499361251332148 article EN cc-by-nc Therapeutic Advances in Infectious Disease 2025-05-01

CD16 is an activating Fc receptor on natural killer cells that mediates antibody-dependent cellular cytotoxicity (ADCC), a key mechanism in antiviral immunity. However, the role of NK cell-mediated ADCC SARS-CoV-2 infection remains unclear, particularly whether it limits viral spread and disease severity or contributes to immunopathogenesis COVID-19. We hypothesized high-affinity CD16AV176 polymorphism influences these outcomes. Using novel vitro reporter system, we demonstrated more potent...

10.1172/jci.insight.191314 article EN cc-by JCI Insight 2025-05-22

Abstract Background Prior reports have suggested a possible increase in the frequency of invasive fungal infections (IFIs) with use Bruton tyrosine kinase inhibitor (BTKi) for treatment chronic lymphoid malignancies such as lymphocytic leukemia (CLL), but precise estimates are lacking. We aim to characterize prevalence IFIs among patients CLL, whom BTKi is now first-line recommended therapy. Methods queried TriNetX, global research network database, identify adult CLL using International...

10.1093/ofid/ofae115 article EN cc-by-nc-nd Open Forum Infectious Diseases 2024-02-28

Abstract Background Leprosy, also known as Hansen's disease, is a chronic infectious disease caused primarily by Mycobacterium leprae, endemic to tropical countries. In 2022, WHO registered 165,459 cases of leprosy. We lack more contemporary clinical descriptions and outcomes the disease. Understanding its characteristics essential for improving diagnosis, treatment, patient outcomes. aim describe manifestations associated with leprosy using "real-world" database. US Map proportion captured...

10.1093/ofid/ofae631.382 article EN cc-by Open Forum Infectious Diseases 2025-01-29

Abstract Background Last-minute travellers (LMTs) present challenges for health care providers because they may have insufficient time recommended vaccinations or pre-travel preparation. Our objective was to obtain a better understanding of LMTs in order help travel medicine develop improved strategies decrease the number and potentially reduce travel-related morbidity. Methods We defined as with departure date 7 days fewer from medical encounter. analysed characteristics preparation 12 494...

10.1093/jtm/taz031 article EN Journal of Travel Medicine 2019-01-01
Coming Soon ...